One of the most influential psychiatrists in the U.S. violated research rules and earned more than $2.8 million in consulting arrangements with drug makers without disclosing much of it to his university, according to this New York Times story on the latest revelations to shake medical circles on cozy relationships with pharmaceutical companies.
TAGS: pharmaceutical, drugs, investigations
No comments:
Post a Comment